{{Rsnum
|rsid=16825455
|Gene=ALPL
|Chromosome=1
|position=21511262
|Orientation=plus
|GMAF=0.2245
|Gene_s=ALPL
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 77.9 | 22.1 | 0.0
| HCB | 51.1 | 40.9 | 8.0
| JPT | 31.9 | 61.1 | 7.1
| YRI | 40.4 | 46.6 | 13.0
| ASW | 54.4 | 38.6 | 7.0
| CHB | 51.1 | 40.9 | 8.0
| CHD | 50.5 | 39.4 | 10.1
| GIH | 86.1 | 13.9 | 0.0
| LWK | 51.8 | 38.2 | 10.0
| MEX | 41.4 | 50.0 | 8.6
| MKK | 47.4 | 42.9 | 9.6
| TSI | 86.3 | 13.7 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=9E-6
  |OR=1.43
  |ORtxt=[1.193-1.702]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}